Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction

This publication has 23 references indexed in Scilit:

• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
  Published by Elsevier ,1992
• Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors
  Journal of the American College of Cardiology, 1992
• Fibrinolytic parameters and hemostatic monitoring: Identifying and predicting patients at risk for major hemorrhagic events
  The American Journal of Cardiology, 1992
• Clinical risks of thrombolytic therapy
  The American Journal of Cardiology, 1992
• Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).
  BMJ, 1991
• Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
  Circulation, 1991
• Stroke complicating thrombolytic therapy of acute myocardial infarction
  Journal of the American College of Cardiology, 1990
• Stroke and acute Myocardial Infarction in the Thrombolytic era: Clinical correlates and long-term prognosis
  Journal of the American College of Cardiology, 1990
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)
  New England Journal of Medicine, 1986